Dexamethasone, CEBM

" If the full published data from the RECOVERY trial of dexamethasone in the treatment of hospitalized patients with COVID-19 confirm the results in the preliminary publications, the decision to adopt it in the NHS before publication of the final paper will have been justified. "
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news